Sanjay K. Juneja, MD, discusses how artificial intelligence has evolved in 2024 to help improve early detection of cancer.
Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses how artificial intelligence has evolved in 2024 to improve early detection of cancer.
Transcription:
0:10 | Artificial intelligence has really given us reason for hope when it comes to detection earlier in cancers, which obviously the hope is that they get cured quicker. I guess there are several examples. One is where they were looking at pancreatic cancer. That's pretty exciting. It was, I think, North Well, Northwell Health and using kind of ai, ai powered technology with MRI and CT scans, what you can do is you can appreciate changes that may be really challenging to notice with the naked eye, right? Just some pixelated changes or things that are happening in the architecture. We are talking about, subtleties so small that it takes something like artificial intelligence kind of powering to compare a whole bunch of things that happened in the past, and then knowing that they turned out to be cancer, that is what primes this AI technology to say, I have seen that before, and I know that X amount of time it actually turns into invasive pancreatic cancer, and is able to clue you in sooner.
1:17 | I think that's the concept behind AI excitement, especially when it relates to imaging, because a lot of times, if you think about it, radiologists do not always get the benefit of seeing a serial number of radiology images and comparing them, knowing kind of at the top of mind that they are all the same patient. They may pull up a previous scan, but that gets very exciting.
1:42 | There are all kinds of imaging that AI is helping to notice these things, especially with breast cancer. There is also technology that's coming out to be able to increase both the sensitivity, so how easily or quickly you can appreciate something while scanning the or doing a mammogram or screening for breast cancer, but also the specificity. A lot of these kinds of false positives or concerns where we end up doing invasive procedures, causes a lot of stress and anxiety. Those can really be reduced by having better imaging techniques. Then, there are a whole bunch of other examples when it comes to AI imaging.
Fedratinib Shows Promise in Chronic Neutrophilic Leukemia and MDS/MPN
January 20th 2025In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with myelodysplastic syndrome/myeloproliferative neoplasms and chronic neutrophilic leukemia.
Read More
Enasidenib Shows Promise as Post-Transplant Maintenance in IDH2-Mutated AML
January 7th 2025Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic stem cell transplant maintenance therapy for IDH2-mutated acute myeloid leukemia treatment.
Read More
Could Triapine With Lutetium 177 Dotatate Improve Outcomes for Neuroendocrine Tumors?
December 30th 2024Aman Chauhan, MD, highlights an ongoing phase 2 trial exploring the combination of triapine, a radiation sensitizer, with lutetium 177 dotatate for treating well-differentiated somatostatin receptor–-positive neuroendocrine tumors.
Read More